Valuing Pharmaceutical Drug Innovations

Valuing Pharmaceutical Drug Innovations

We propose a methodology to estimate the market value of pharmaceutical drugs. Our approach combines an event study with a model of discounted cash flows and uses stock market responses to drug development announcements to infer the values. We estimate that, on average, a successful drug is valued a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:arXiv.org 2024-04
Hauptverfasser: Aryal, Gaurab, Ciliberto, Federico, Farmer, Leland E, Khmelnitskaya, Ekaterina
Format: Artikel
Sprache:eng
Schlagworte:
Drugs
Innovations
Market value
Pharmaceuticals
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title arXiv.org
container_volume
creator Aryal, Gaurab
Ciliberto, Federico
Farmer, Leland E
Khmelnitskaya, Ekaterina
description We propose a methodology to estimate the market value of pharmaceutical drugs. Our approach combines an event study with a model of discounted cash flows and uses stock market responses to drug development announcements to infer the values. We estimate that, on average, a successful drug is valued at \$1.62 billion, and its value at the discovery stage is \$64.3 million, with substantial heterogeneity across major diseases. Leveraging these estimates, we also determine the average drug development costs at various stages. Furthermore, we explore applying our estimates to design policies that support drug development through drug buyouts and cost-sharing agreements.
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_2754662612</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2754662612</sourcerecordid><originalsourceid>FETCH-proquest_journals_27546626123</originalsourceid><addsrcrecordid>eNpjYuA0MjY21LUwMTLiYOAtLs4yMDAwMjM3MjU15mRQD0vMKc3MS1cIyEgsyk1MTi0tyUxOzFFwKSpNV_DMy8svSyzJzM8r5mFgTUvMKU7lhdLcDMpuriHOHroFRfmFpanFJfFZ-aVFeUCpeCNzUxMzMyMzQyNj4lQBAIrIMAE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2754662612</pqid></control><display><type>article</type><title>Valuing Pharmaceutical Drug Innovations</title><source>Free E- Journals</source><creator>Aryal, Gaurab ; Ciliberto, Federico ; Farmer, Leland E ; Khmelnitskaya, Ekaterina</creator><creatorcontrib>Aryal, Gaurab ; Ciliberto, Federico ; Farmer, Leland E ; Khmelnitskaya, Ekaterina</creatorcontrib><description>We propose a methodology to estimate the market value of pharmaceutical drugs. Our approach combines an event study with a model of discounted cash flows and uses stock market responses to drug development announcements to infer the values. We estimate that, on average, a successful drug is valued at \$1.62 billion, and its value at the discovery stage is \$64.3 million, with substantial heterogeneity across major diseases. Leveraging these estimates, we also determine the average drug development costs at various stages. Furthermore, we explore applying our estimates to design policies that support drug development through drug buyouts and cost-sharing agreements.</description><identifier>EISSN: 2331-8422</identifier><language>eng</language><publisher>Ithaca: Cornell University Library, arXiv.org</publisher><subject>Drugs ; Innovations ; Market value ; Pharmaceuticals</subject><ispartof>arXiv.org, 2024-04</ispartof><rights>2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>776,780</link.rule.ids></links><search><creatorcontrib>Aryal, Gaurab</creatorcontrib><creatorcontrib>Ciliberto, Federico</creatorcontrib><creatorcontrib>Farmer, Leland E</creatorcontrib><creatorcontrib>Khmelnitskaya, Ekaterina</creatorcontrib><title>Valuing Pharmaceutical Drug Innovations</title><title>arXiv.org</title><description>We propose a methodology to estimate the market value of pharmaceutical drugs. Our approach combines an event study with a model of discounted cash flows and uses stock market responses to drug development announcements to infer the values. We estimate that, on average, a successful drug is valued at \$1.62 billion, and its value at the discovery stage is \$64.3 million, with substantial heterogeneity across major diseases. Leveraging these estimates, we also determine the average drug development costs at various stages. Furthermore, we explore applying our estimates to design policies that support drug development through drug buyouts and cost-sharing agreements.</description><subject>Drugs</subject><subject>Innovations</subject><subject>Market value</subject><subject>Pharmaceuticals</subject><issn>2331-8422</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpjYuA0MjY21LUwMTLiYOAtLs4yMDAwMjM3MjU15mRQD0vMKc3MS1cIyEgsyk1MTi0tyUxOzFFwKSpNV_DMy8svSyzJzM8r5mFgTUvMKU7lhdLcDMpuriHOHroFRfmFpanFJfFZ-aVFeUCpeCNzUxMzMyMzQyNj4lQBAIrIMAE</recordid><startdate>20240413</startdate><enddate>20240413</enddate><creator>Aryal, Gaurab</creator><creator>Ciliberto, Federico</creator><creator>Farmer, Leland E</creator><creator>Khmelnitskaya, Ekaterina</creator><general>Cornell University Library, arXiv.org</general><scope>8FE</scope><scope>8FG</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>HCIFZ</scope><scope>L6V</scope><scope>M7S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope></search><sort><creationdate>20240413</creationdate><title>Valuing Pharmaceutical Drug Innovations</title><author>Aryal, Gaurab ; Ciliberto, Federico ; Farmer, Leland E ; Khmelnitskaya, Ekaterina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_27546626123</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Drugs</topic><topic>Innovations</topic><topic>Market value</topic><topic>Pharmaceuticals</topic><toplevel>online_resources</toplevel><creatorcontrib>Aryal, Gaurab</creatorcontrib><creatorcontrib>Ciliberto, Federico</creatorcontrib><creatorcontrib>Farmer, Leland E</creatorcontrib><creatorcontrib>Khmelnitskaya, Ekaterina</creatorcontrib><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Technology Collection (ProQuest)</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Engineering Collection</collection><collection>Engineering Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aryal, Gaurab</au><au>Ciliberto, Federico</au><au>Farmer, Leland E</au><au>Khmelnitskaya, Ekaterina</au><format>book</format><genre>document</genre><ristype>GEN</ristype><atitle>Valuing Pharmaceutical Drug Innovations</atitle><jtitle>arXiv.org</jtitle><date>2024-04-13</date><risdate>2024</risdate><eissn>2331-8422</eissn><abstract>We propose a methodology to estimate the market value of pharmaceutical drugs. Our approach combines an event study with a model of discounted cash flows and uses stock market responses to drug development announcements to infer the values. We estimate that, on average, a successful drug is valued at \$1.62 billion, and its value at the discovery stage is \$64.3 million, with substantial heterogeneity across major diseases. Leveraging these estimates, we also determine the average drug development costs at various stages. Furthermore, we explore applying our estimates to design policies that support drug development through drug buyouts and cost-sharing agreements.</abstract><cop>Ithaca</cop><pub>Cornell University Library, arXiv.org</pub><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier EISSN: 2331-8422
ispartof arXiv.org, 2024-04
issn 2331-8422
language eng
recordid cdi_proquest_journals_2754662612
source Free E- Journals
subjects Drugs
Innovations
Market value
Pharmaceuticals
title Valuing Pharmaceutical Drug Innovations
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T07%3A30%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=document&rft.atitle=Valuing%20Pharmaceutical%20Drug%20Innovations&rft.jtitle=arXiv.org&rft.au=Aryal,%20Gaurab&rft.date=2024-04-13&rft.eissn=2331-8422&rft_id=info:doi/&rft_dat=%3Cproquest%3E2754662612%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2754662612&rft_id=info:pmid/&rfr_iscdi=true